| ■ 영문 제목 : Global Age-related Macular Degeneration Market 2023-2027
|
 | ■ 상품코드 : IRTNTR70644-23
■ 조사/발행회사 : Technavio
■ 발행일 : 2023년 1월
■ 페이지수 : 154
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (24시간 이내)
■ 조사대상 지역 : 북미, 유럽, 아시아, 기타 지역
■ 산업 분야 : 의료
|
■ 판매가격 / 옵션
(부가세 10% 별도)
| Single User (1명 열람용) | USD2,500 ⇒환산￦3,375,000 | 견적의뢰/주문/질문 |
| Enterprise License (동일기업내 공유가능) | USD4,000 ⇒환산￦5,400,000 | 견적의뢰/주문/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
Technavio사의 본 조사 보고서는 세계의 노인 황반 변성 (AMD) 시장 규모가 2022년부터 2027년 사이에 4,360.68백만달러에 달하며, 예측기간 동안 연평균 5.95% 성장할 것으로 전망하고 있습니다. 또한 본 조사 자료는 세계의 노인 황반 변성 (AMD) 시장에 대해 조사하여, 개요, 시장 현황, 시장 규모 및 예측, 과거 시장 규모, Five Force 분석, 종류별 (습식 AMD, 건식 AMD) 분석, 유통 채널별 (병원 약국, 전문 약국, 온라인 약국) 분석, 고객 현황, 지역별 (북미, 유럽, 아시아, 기타 지역, 미국, 독일, 영국, 프랑스, 일본) 분석, 성장 요인/과제/동향, 기업 현황, 기업 분석 등의 내용을 게재하고 있습니다. 또한 본 문서는 AbbVie Inc., Adverum Biotechnologies Inc., Alimera Sciences Inc., Alkeus Pharmaceuticals Inc., Amgen Inc., Apellis Pharmaceuticals Inc., Bausch Health Co Inc., Bayer AG, Biocon Ltd., Bio-Thera Bio Pharmaceutical Co. Ltd., F. Hoffmann La Roche Ltd., IVERIC bio Inc., Lupin Ltd., Novartis AG, Outlook Therapeutics Inc., Pfizer Inc. 등의 기업 정보가 포함되어 있습니다.
・개요
・시장 현황
・시장 규모 및 예측
・과거 시장 규모
・Five Force 분석
・세계의 노인 황반 변성 (AMD) 시장 규모 : 종류별
- 습식 AMD의 시장 규모
- 건식 AMD의 시장 규모
・세계의 노인 황반 변성 (AMD) 시장 규모 : 유통 채널별
- 병원 약국 채널의 시장 규모
- 전문 약국 채널의 시장 규모
- 온라인 약국 채널의 시장 규모
・고객 현황
・세계의 노인 황반 변성 (AMD) 시장 규모 : 지역별
- 북미의 노화 황반 변성 (AMD) 시장 규모
- 유럽의 노인 황반 변성 (AMD) 시장 규모
- 아시아의 노인 황반 변성 (AMD) 시장 규모
- 기타 지역의 노인 황반 변성 (AMD) 시장 규모
- 미국의 노인 황반 변성 (AMD) 시장 규모
- 독일의 노인 황반 변성 (AMD) 시장 규모
- 영국의 노화 황반 변성 (AMD) 시장 규모
- 프랑스의 노인 황반 변성 (AMD) 시장 규모
- 일본의 노인 황반 변성 (AMD) 시장 규모
・성장 요인/과제/동향
・기업 현황
・기업 분석
Technavio 사는 이익, 가격, 경쟁, 프로모션과 같은 주요 매개 변수를 분석하여, 다수의 소스로부터 데이터를 조사, 통합 및 합산하여 시장에 대한 상세하고 종합적인 결과를 제공합니다. 또한, 주요 산업의 영향 요인을 분석하여 시장의 다양한 관점을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 덧붙여 Technavio 사의 시장 조사 보고서는 정확한 시장 성장을 예측하기 위해, 정성적 및 정량적 조사를 사용하여, 명확한 경쟁 현황과 상세한 벤더 선택 방법 및 분석을 제공합니다. |
■ 보고서 개요Global Age-related Macular Degeneration Market 2023-2027
Technavio has been monitoring the age-related macular degeneration market and is forecast to grow by $4,360.68 mn during 2022-2027, accelerating at a CAGR of 5.95% during the forecast period. Our report on the age-related macular degeneration market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the high prevalence of AMD, strong pipeline and expected approvals, and rising geriatric population.
Technavio’s age-related macular degeneration market is segmented as below:
By Type
• Wet AMD
• Dry AMD
By Distribution Channel
• Hospital pharmacy
• Specialty pharmacy
• Online pharmacy
By Geography
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies strategic alliances as one of the prime reasons driving the age-related macular degeneration market growth during the next few years. Also, the development of gene therapy for AMD and growing awareness of AMD will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the age-related macular degeneration market covers the following areas:
• Age-related macular degeneration market sizing
• Age-related macular degeneration market forecast
• Age-related macular degeneration market industry analysis
Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading age-related macular degeneration market vendors that include AbbVie Inc., Adverum Biotechnologies Inc., Alimera Sciences Inc., Alkeus Pharmaceuticals Inc., Amgen Inc., Apellis Pharmaceuticals Inc., Bausch Health Co Inc., Bayer AG, Biocon Ltd., Bio-Thera Bio Pharmaceutical Co. Ltd., F. Hoffmann La Roche Ltd., IVERIC bio Inc., Lupin Ltd., Novartis AG, Outlook Therapeutics Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., Ribomic Inc., Viatris Inc., and Xbrane Biopharma AB. Also, the age-related macular degeneration market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary.
Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
■ 보고서 목차• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global age-related macular degeneration market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global age-related macular degeneration market 2017 – 2021 ($ million)
o 4.2 Type Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
o 4.3 Distribution Channel Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type – Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Wet AMD – Market size and forecast 2022-2027
o Exhibit 34: Chart on Wet AMD – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Wet AMD – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Wet AMD – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Wet AMD – Year-over-year growth 2022-2027 (%)
o 6.4 Dry AMD – Market size and forecast 2022-2027
o Exhibit 38: Chart on Dry AMD – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Dry AMD – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Dry AMD – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Dry AMD – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 43: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 44: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 45: Chart on Comparison by Distribution Channel
o Exhibit 46: Data Table on Comparison by Distribution Channel
o 7.3 Hospital pharmacy – Market size and forecast 2022-2027
o Exhibit 47: Chart on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
o 7.4 Specialty pharmacy – Market size and forecast 2022-2027
o Exhibit 51: Chart on Specialty pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Specialty pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Specialty pharmacy – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Specialty pharmacy – Year-over-year growth 2022-2027 (%)
o 7.5 Online pharmacy – Market size and forecast 2022-2027
o Exhibit 55: Chart on Online pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Online pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Online pharmacy – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Online pharmacy – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 59: Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 61: Chart on Market share by geography 2022-2027 (%)
o Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 63: Chart on Geographic comparison
o Exhibit 64: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 65: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 81: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 UK – Market size and forecast 2022-2027
o Exhibit 89: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.10 France – Market size and forecast 2022-2027
o Exhibit 93: Chart on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on France – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on France – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 97: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 101: Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 102: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 104: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 105: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 106: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 107: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 108: AbbVie Inc. – Overview
o Exhibit 109: AbbVie Inc. – Product / Service
o Exhibit 110: AbbVie Inc. – Key news
o Exhibit 111: AbbVie Inc. – Key offerings
o 12.4 Alkeus Pharmaceuticals Inc.
o Exhibit 112: Alkeus Pharmaceuticals Inc. – Overview
o Exhibit 113: Alkeus Pharmaceuticals Inc. – Product / Service
o Exhibit 114: Alkeus Pharmaceuticals Inc. – Key offerings
o 12.5 Amgen Inc.
o Exhibit 115: Amgen Inc. – Overview
o Exhibit 116: Amgen Inc. – Product / Service
o Exhibit 117: Amgen Inc. – Key offerings
o 12.6 Apellis Pharmaceuticals Inc.
o Exhibit 118: Apellis Pharmaceuticals Inc. – Overview
o Exhibit 119: Apellis Pharmaceuticals Inc. – Product / Service
o Exhibit 120: Apellis Pharmaceuticals Inc. – Key offerings
o 12.7 Bausch Health Co Inc.
o Exhibit 121: Bausch Health Co Inc. – Overview
o Exhibit 122: Bausch Health Co Inc. – Business segments
o Exhibit 123: Bausch Health Co Inc. – Key news
o Exhibit 124: Bausch Health Co Inc. – Key offerings
o Exhibit 125: Bausch Health Co Inc. – Segment focus
o 12.8 Bayer AG
o Exhibit 126: Bayer AG – Overview
o Exhibit 127: Bayer AG – Business segments
o Exhibit 128: Bayer AG – Key news
o Exhibit 129: Bayer AG – Key offerings
o Exhibit 130: Bayer AG – Segment focus
o 12.9 Biocon Ltd.
o Exhibit 131: Biocon Ltd. – Overview
o Exhibit 132: Biocon Ltd. – Business segments
o Exhibit 133: Biocon Ltd. – Key offerings
o Exhibit 134: Biocon Ltd. – Segment focus
o 12.10 Bio-Thera Bio Pharmaceutical Co. Ltd.
o Exhibit 135: Bio-Thera Bio Pharmaceutical Co. Ltd. – Overview
o Exhibit 136: Bio-Thera Bio Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 137: Bio-Thera Bio Pharmaceutical Co. Ltd. – Key offerings
o 12.11 F. Hoffmann La Roche Ltd.
o Exhibit 138: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 139: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 140: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 141: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 142: F. Hoffmann La Roche Ltd. – Segment focus
o 12.12 IVERIC bio Inc.
o Exhibit 143: IVERIC bio Inc. – Overview
o Exhibit 144: IVERIC bio Inc. – Product / Service
o Exhibit 145: IVERIC bio Inc. – Key offerings
o 12.13 Lupin Ltd.
o Exhibit 146: Lupin Ltd. – Overview
o Exhibit 147: Lupin Ltd. – Product / Service
o Exhibit 148: Lupin Ltd. – Key news
o Exhibit 149: Lupin Ltd. – Key offerings
o 12.14 Novartis AG
o Exhibit 150: Novartis AG – Overview
o Exhibit 151: Novartis AG – Business segments
o Exhibit 152: Novartis AG – Key offerings
o Exhibit 153: Novartis AG – Segment focus
o 12.15 Outlook Therapeutics Inc.
o Exhibit 154: Outlook Therapeutics Inc. – Overview
o Exhibit 155: Outlook Therapeutics Inc. – Product / Service
o Exhibit 156: Outlook Therapeutics Inc. – Key offerings
o 12.16 Pfizer Inc.
o Exhibit 157: Pfizer Inc. – Overview
o Exhibit 158: Pfizer Inc. – Product / Service
o Exhibit 159: Pfizer Inc. – Key news
o Exhibit 160: Pfizer Inc. – Key offerings
o 12.17 Regeneron Pharmaceuticals Inc.
o Exhibit 161: Regeneron Pharmaceuticals Inc. – Overview
o Exhibit 162: Regeneron Pharmaceuticals Inc. – Product / Service
o Exhibit 163: Regeneron Pharmaceuticals Inc. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 164: Inclusions checklist
o Exhibit 165: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 166: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 167: Research methodology
o Exhibit 168: Validation techniques employed for market sizing
o Exhibit 169: Information sources
o 13.5 List of abbreviations
o Exhibit 170: List of abbreviations
Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global age-related macular degeneration market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Type – Market share 2022-2027 (%)
Exhibits31: Data Table on Type – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Wet AMD – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Wet AMD – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Wet AMD – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Wet AMD – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Dry AMD – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Dry AMD – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Dry AMD – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Dry AMD – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits44: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Distribution Channel
Exhibits46: Data Table on Comparison by Distribution Channel
Exhibits47: Chart on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Specialty pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Specialty pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Specialty pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Specialty pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Online pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Online pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Online pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Online pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by Distribution Channel ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share by geography 2022-2027 (%)
Exhibits62: Data Table on Market share by geography 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on France – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on France – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on France – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on France – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity by geography ($ million)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: AbbVie Inc. – Overview
Exhibits109: AbbVie Inc. – Product / Service
Exhibits110: AbbVie Inc. – Key news
Exhibits111: AbbVie Inc. – Key offerings
Exhibits112: Alkeus Pharmaceuticals Inc. – Overview
Exhibits113: Alkeus Pharmaceuticals Inc. – Product / Service
Exhibits114: Alkeus Pharmaceuticals Inc. – Key offerings
Exhibits115: Amgen Inc. – Overview
Exhibits116: Amgen Inc. – Product / Service
Exhibits117: Amgen Inc. – Key offerings
Exhibits118: Apellis Pharmaceuticals Inc. – Overview
Exhibits119: Apellis Pharmaceuticals Inc. – Product / Service
Exhibits120: Apellis Pharmaceuticals Inc. – Key offerings
Exhibits121: Bausch Health Co Inc. – Overview
Exhibits122: Bausch Health Co Inc. – Business segments
Exhibits123: Bausch Health Co Inc. – Key news
Exhibits124: Bausch Health Co Inc. – Key offerings
Exhibits125: Bausch Health Co Inc. – Segment focus
Exhibits126: Bayer AG – Overview
Exhibits127: Bayer AG – Business segments
Exhibits128: Bayer AG – Key news
Exhibits129: Bayer AG – Key offerings
Exhibits130: Bayer AG – Segment focus
Exhibits131: Biocon Ltd. – Overview
Exhibits132: Biocon Ltd. – Business segments
Exhibits133: Biocon Ltd. – Key offerings
Exhibits134: Biocon Ltd. – Segment focus
Exhibits135: Bio-Thera Bio Pharmaceutical Co. Ltd. – Overview
Exhibits136: Bio-Thera Bio Pharmaceutical Co. Ltd. – Product / Service
Exhibits137: Bio-Thera Bio Pharmaceutical Co. Ltd. – Key offerings
Exhibits138: F. Hoffmann La Roche Ltd. – Overview
Exhibits139: F. Hoffmann La Roche Ltd. – Business segments
Exhibits140: F. Hoffmann La Roche Ltd. – Key news
Exhibits141: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits142: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits143: IVERIC bio Inc. – Overview
Exhibits144: IVERIC bio Inc. – Product / Service
Exhibits145: IVERIC bio Inc. – Key offerings
Exhibits146: Lupin Ltd. – Overview
Exhibits147: Lupin Ltd. – Product / Service
Exhibits148: Lupin Ltd. – Key news
Exhibits149: Lupin Ltd. – Key offerings
Exhibits150: Novartis AG – Overview
Exhibits151: Novartis AG – Business segments
Exhibits152: Novartis AG – Key offerings
Exhibits153: Novartis AG – Segment focus
Exhibits154: Outlook Therapeutics Inc. – Overview
Exhibits155: Outlook Therapeutics Inc. – Product / Service
Exhibits156: Outlook Therapeutics Inc. – Key offerings
Exhibits157: Pfizer Inc. – Overview
Exhibits158: Pfizer Inc. – Product / Service
Exhibits159: Pfizer Inc. – Key news
Exhibits160: Pfizer Inc. – Key offerings
Exhibits161: Regeneron Pharmaceuticals Inc. – Overview
Exhibits162: Regeneron Pharmaceuticals Inc. – Product / Service
Exhibits163: Regeneron Pharmaceuticals Inc. – Key offerings
Exhibits164: Inclusions checklist
Exhibits165: Exclusions checklist
Exhibits166: Currency conversion rates for US$
Exhibits167: Research methodology
Exhibits168: Validation techniques employed for market sizing
Exhibits169: Information sources
Exhibits170: List of abbreviations
|
| ※본 조사보고서 [세계의 노인 황반 변성 (AMD) 시장 (2023년~2027년)] (코드 : IRTNTR70644-23) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 노인 황반 변성 (AMD) 시장 (2023년~2027년)] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!
